Jette Primdahl,Lisbeth Skovly Nielsen
Jette Primdahl
Towards global clinical practice guidelines for the management of non-specific low back pain in primary care: a review of current guideline recommendations and how they have changed over the last 30 years [0.03%]
迈向全球临床实践指南：三十年来针对初级保健中非特异性下腰痛管理的现行指南建议及其变化综述
Crystian B Oliveira,Bart W Koes,Rafael Z Pinto et al.
Crystian B Oliveira et al.
Low back pain has an enormous impact on individuals and health systems. The large majority of individuals with low back pain have non-specific low back pain (also recently called primary low back pain by WHO), where the cause cannot be attr...
The Lancet Rheumatology
The Lancet Rheumatology
Amelia Holloway,Dreen Gul,Alexandra E Oppong et al.
Amelia Holloway et al.
Repurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial [0.03%]
将来氟米特和羟氯喹重新用于治疗舍格伦综合征（RepurpSS-II）：一项随机、双盲、安慰剂对照的Ⅱb期试验
Wing-Yi Wong,Dewi Rijnenberg,Valentin M D Baloche et al.
Wing-Yi Wong et al.
Background: Sjögren's disease is a systemic autoimmune disease characterised by secretory gland dysfunction that lacks effective systemic treatment. We aimed to replicate the findings of the RepurpSS-I trial and determin...
Dana Guglielmo
Dana Guglielmo
Leflunomide-hydroxychloroquine: a replicable hope in Sjögren's disease? [0.03%]
来氟米特-羟氯喹：自身免疫性干燥综合征的可重复希望吗？
Gaetane Nocturne
Gaetane Nocturne
Long-term treatment transition patterns after intensive treatment strategies in early psoriatic arthritis: insights from the GOLMePsA clinical trial [0.03%]
早期银屑病关节炎强化治疗后的长期治疗模式转变：GOLMePsA临床试验启示
Katya Meridor,Raquel Granados,Stephanie R Harrison et al.
Katya Meridor et al.
When one joint matters: the monoarticular blind spot in inflammatory arthritis [0.03%]
当一个关节很重要时：炎性关节病的单关节盲点
Francesco Ursini,Jacopo Ciaffi,Salvatore D&#x;Angelo et al.
Francesco Ursini et al.
Monoarthritis is a familiar-yet systematically under-theorised-scenario in rheumatoid arthritis and psoriatic arthritis, occurring both at onset and as residual synovitis that persists despite apparently successful treat-to-target care. Con...